3+ hour, 24+ min ago  (411+ words) After nearly nine months of holding out, Regeneron has finally agreed to fall in line with the Trump administration's Most Favored Nation pricing push. Thursday evening, just hours after announcing the FDA approval for its hearing loss gene therapy Otarmeni,…...

2+ week, 6+ day ago  (523+ words) The Trump administration has imposed a 100% tariff on imports of patented pharmaceutical products and ingredients. However, analysts predicted the action will have a limited effect on many companies. One year after proposing its "Liberation Day" tariffs, the Trump administration has…...

3+ week, 2+ day ago  (485+ words) Companies have questioned whether they can limit launches to the markets where they can charge the most to avoid eroding U. S. prices, Majewski explained. However, that approach has a flaw. As Eva Marchese, vice president at CRA, told Bio Space, a…...

2+ mon, 2+ week ago  (567+ words) Bio Space Pfizer Launches Cost Savings Program on Trump Rx Lowering Drug Costs for Millions of Americans - Program offers significant savings on over 30 brands spanning women's health, migraine, arthritis, rare disease and more - Affirms Pfizer's commitment to reduce drug costs…...

2+ mon, 3+ week ago  (369+ words) Flickr, White House/Daniel Torok The White House has delayed the launch of Trump Rx, the federal government's proposed marketplace that will allow patients to purchase their medicines directly from pharma companies. "In any other administration, it would 100 percent be…...

3+ mon, 1+ week ago  (771+ words) Acadia CEO Catherine Owen Adams, After a year of watching major pharma companies in the Trump administration's hot seat for drug pricing, Acadia Pharmaceuticals CEO Catherine Owen Adams isn't taking any chances. The CEO is one of the founders of…...

3+ mon, 1+ week ago  (468+ words) President Donald Trump unveiled "The Great Healthcare Plan" on Thursday, calling on Congress to enact changes to lower drug prices and insurance premiums and stretch Most Favored Nation drug pricing beyond the 17 pharma companies that were targeted last year. Speaking…...

3+ mon, 2+ week ago  (164+ words) The analysis reviewed wholesale acquisition cost (WAC) trends across the top-spend Medicare drugs. While multiple provisions of the IRA have not yet been implemented and market dynamics also influence manufacturer decisions, early observations of the IRA's potential effects on medication…...

3+ mon, 3+ week ago  (248+ words) Drugmakers plan to raise the U. S. prices of 40% more drugs in 2026 than they did in 2025despite pressure from President Donald Trump to charge less. Specifically, more than a dozen Big Pharmas have now reached Most Favored Nation agreements with the White House....

5+ mon, 1+ week ago  (1731+ words) President Donald Trump has made lowering drug prices a cornerstone of his domestic policy agenda, the core of which is his Most Favored Nation (MFN) scheme, which seeks to force U. S. drug prices down to the same level as in similarly…...